Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Diaceutics ( (GB:DXRX) ) has issued an update.
Diaceutics PLC has announced the posting of its Annual Report for the year ended 31 December 2024, along with the Notice of the 2025 Annual General Meeting (AGM) to shareholders. The AGM is scheduled for 18 June 2025 in Belfast, and the documents will be accessible on the company’s website, indicating a transparent approach to stakeholder engagement and corporate governance.
The most recent analyst rating on (GB:DXRX) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Diaceutics stock, see the GB:DXRX Stock Forecast page.
More about Diaceutics
Diaceutics PLC is a leading technology and solutions provider to the pharma and biotech industry, offering an end-to-end commercialization solution for precision medicines. Their services include data analytics, scientific and advisory services, all facilitated by their platform DXRX – The Diagnostics Network®.
Average Trading Volume: 116,691
Technical Sentiment Signal: Buy
Current Market Cap: £111.5M
For an in-depth examination of DXRX stock, go to TipRanks’ Stock Analysis page.